LPL Financial’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.8K | Sell |
|
|||||
|
2025
Q1 | $14.8K | Buy |
|
|||||
|
2024
Q4 | $15.4K | Sell |
|
|||||
|
2024
Q3 | $27.8K | Sell |
|
|||||
|
2024
Q2 | $31.4K | Sell |
|
|||||
|
2024
Q1 | $61.4K | Sell |
|
|||||
|
2023
Q4 | $88.3K | Sell |
|
|||||
|
2023
Q3 | $113K | Sell |
|
|||||
|
2023
Q2 | $164K | Sell |
|
|||||
|
2023
Q1 | $195K | Sell |
|
|||||
|
2022
Q4 | $176K | Sell |
|
|||||
|
2022
Q3 | $214K | Sell |
|
|||||
|
2022
Q2 | $378K | Buy |
|
|||||
|
2022
Q1 | $242K | Buy |
|
|||||
|
2021
Q4 | $269K | Buy |
|
|||||
|
2021
Q3 | $221K | Buy |
|
|||||
|
2021
Q2 | $172K | Buy |
|
|||||
|
2021
Q1 | $112K | Buy |
|
|||||
|
2020
Q4 | $44K | Buy |
|
|||||
|
2020
Q3 | $23K | Sell |
|
|||||
|
2020
Q2 | $22K | Buy |
|
|||||
|
2020
Q1 | $13K | Sell |
|
|||||
|
2019
Q4 | $15K | Sell |
|
|||||
|
2019
Q3 | $17K | Sell |
|
|||||
|
2019
Q2 | $62K | Sell |
|
|||||
|
2019
Q1 | $74K | Buy |
|
|||||
|
2018
Q4 | $47K | Buy |
|
|||||
|
2018
Q3 | $25K | Buy |
|
|||||
|
2018
Q2 | $21K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $52K | Buy |
|
|||||
|
2015
Q1 | $70K | Buy |
|